Track market-moving stories before they get noisy

NEW YORK--(BUSINESS WIRE)--Steel Partners Holdings L.P. (together with its affiliates, “Steel”), a significant, long-standing shareholder of InMode Ltd. (“InMode” or the “Company”) (Nasdaq: INMD), today issued a letter to the Board of Directors (the “Board”) of the Company. The full text of the letter is below. July 16, 2026 VIA ELECTRONIC MAIL InMode Ltd. Tavor Building, Sha'ar Yokneam P.O. Box 533 Yokneam 2069206 Israel Attention: The Board of Directors Dear Members of the Board of Directors:.

, /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) (the "Company") confirmed that its Board of Directors (the "Board") has received the unsolicited letter and acquisition proposal from Steel Partners Holdings L.P. dated July 9, 2026.

The Special Committee comprised solely of the independent directors of the Board (the "Special Committee"), together with its legal and financial advisors, will carefully review the proposal consistent with its fiduciary duties.

The Special Committee remains committed to acting in the best interests of all shareholders. The Special Committee does not intend to comment further at this time.

About InMode Ltd.

The Company is a leading global provider of innovative medical technologies. The Company develops, manufactures and markets devices harnessing novel radiofrequency ("RF") technology. The Company strives to enable new emerging surgical procedures as well as improve existing treatments. The Company has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. For more information about the Company and its wide array of medical technologies, visit www.inmodemd.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. In some cases, forward-looking statements can be identified by terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "will," "would" or the negative of those terms or other comparable terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding the Proposal, the special committee's review and evaluation of the Proposal, the potential consummation of any transaction and the Company's future plans, objectives, expectations and intentions. These statements involve known and unknown risks, uncertainties, and other factors that may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied. Such factors include, among others: uncertainties as to whether the special committee will determine that the Proposal or any alternative transaction is in the best interests of the Company and its shareholders; the risk that the Proposal may be withdrawn or modified; the possibility that competing offers or alternatives may or may not emerge; the risk that any transaction may not be consummated on the terms or timeline currently contemplated, or at all; and the other risks described in the Company's filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise except as required by law.

Contacts

Miri Segal-Scharia
MS-IR LLC
[email protected]

Logo: https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

SOURCE InMode Ltd.

-

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of InMode Ltd. (“InMode” or the “Company”) (NASDAQ: INMD) investors concerning the Company’s possible violations of the federal securities laws.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON INMODE LTD. (INMD), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

What Happened?

On June 30, 2026, a longstanding shareholder of InMode, Steel Partners Holdings L.P., issued a public letter to InMode’s Board of Directors, stating that “over the last six months,” the Company has displayed “a series of disastrous governance failures that have created a situation wherein its own CEO may be able to acquire the Company at a price below what the Board previously rejected.” Specifically, the letter claims that InMode’s Chief Executive Officer “accumulated roughly 800,000 shares in open-market purchases between February 24[, 2026] and March 10, 2026 — in the narrow window surrounding material corporate events, including the March 13, 2026 buyback announcement that moved the stock nearly 6%. These purchases are consistent with trading while in possession of material non-public information and with usurpation of a corporate opportunity belonging to the Company and all of its shareholders.”

Contact Us To Participate or Learn More:

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

Whistleblower Notice

Persons with non-public information regarding InMode should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email [email protected].

About Glancy Prongay Wolke & Rotter LLP

GPWR is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Recognizing the firm’s recent successes, GPWR was named one of Law360’s Securities Groups of the Year and ranked second-highest in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025. GPWR’s lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPWR’s past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron’s, Investor’s Business Daily, Forbes, and Money. Prior results do not guarantee a similar outcome.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

More News From Glancy Prongay Wolke & Rotter LLP

Back to Newsroom

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of InMode Ltd. (“InMode” or the “Company”) (NASDAQ: INMD) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INMODE LTD. (INMD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@.

DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual) DOMA ASSERTS THAT THE $16.20 PER SHARE OFFER MATERIALLY UNDERVALUES INMODE AND ITS LONG-TERM POTENTIAL

DOMA BELIEVES THE BID EXPLOITS THE DEPRESSED VALUATIONS CREATED BY YEARS OF CEO-LED UNDERPERFORMANCE

DOMA EXPLICITLY REJECTS THE CURRENT TERMS AND URGES THE BOARD TO UPLHOLD ITS FIDUCIARY DUTIES

, /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a letter to the Board of Directors of InMode (the "Board").

The letter can be downloaded here

The full text of the letter follows:

June 26, 2026

To the Board Member of InMode:

As of the date of this letter, DOMA Perpetual Capital Management LLC ("DOMA") and its affiliates beneficially own approximately 4.63% of the outstanding ordinary shares of InMode Ltd. ("InMode" or the "Company").

We are writing as a concerned shareholder regarding the recently proposed acquisition of the Company led by the Chief Executive Officer in partnership with a group of investors. The circumstances surrounding this proposal raise serious concerns about conflicts of interest, governance, the Board's fiduciary responsibilities, and the fairness of the proposed transaction.

We believe the proposal materially undervalues the Company, particularly in light of its long-term potential and intrinsic assets. It is difficult to ignore that this proposal also follows a long period of operational underperformance under the current CEO's leadership. We have previously asked the Board, in a public communication dated May 9, 2025, to replace the CEO precisely because of his sustained underperformance, and that same CEO now appears positioned to benefit from the proposed transaction.1 In our view, these circumstances warrant close scrutiny, and DOMA reserves all of its rights in connection with the proposed transaction.

We strongly believe the proposal would allow management to capitalize on a depressed valuation that developed during its own stewardship and that, in our view, management's performance helped create. Such dynamics are deeply troubling from a governance perspective.

The Board has fiduciary obligations to act in the best interests of all shareholders, not management or any specific investor group. In this context, we urge the Board to take the following actions:

Establish a fully independent special committee with no ties to management to evaluate the proposal. Retain international independent financial and legal advisors to conduct a rigorous valuation and fairness assessment. Conduct a broad and transparent market check inviting public offers to determine whether superior offers exist. Ensure that shareholders are provided with full and fair disclosure regarding the process, assumptions, and any potential conflicts of interest. Any transaction that allows insiders to acquire the Company at a price influenced by their own stewardship must be subject to the highest level of scrutiny. Failure to do so could expose the Company and the Board to significant shareholder value destruction, as well as reputational and legal risk.

Shareholders rely on the Board to uphold strong governance standards and to protect against precisely this type of conflicted transaction. I trust that you will take these responsibilities seriously and act accordingly.

At the current offer of $16.20/share DOMA does not support the proposal and intends to vote against the transaction.

Sincerely,

Pedro Escudero
CEO & CIO
DOMA Perpetual Capital Management LLC

This letter has been prepared by DOMA. The views expressed herein reflect DOMA's opinions and are based on publicly available information regarding the Company. DOMA recognizes that the Company or others may have information not available to DOMA that could lead them to disagree with DOMA's views or conclusions. DOMA reserves the right to change or modify its views, opinions, intentions, or positions at any time and for any reason, and disclaims any obligation to update or revise the information contained herein, except as may be required by applicable law.

This letter was not prepared by, and has not been endorsed by, InMode Ltd. This letter is provided for informational purposes only and is not intended to be, and should not be construed as, an offer to sell or a solicitation of an offer to buy any security, or as a recommendation to purchase or sell any security. DOMA is not currently soliciting proxies, consents, authorizations, or voting commitments with respect to any securities of the Company. One or more funds managed by DOMA currently beneficially own shares of the Company.

Certain statements in this letter may constitute forward-looking statements. These statements reflect DOMA's current views and expectations, speak only as of the date hereof, and are subject to risks, uncertainties, and assumptions that could cause actual results or developments to differ materially from those expressed or implied.

PR Newswire, May 9, 2025, DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program (urging the Board, among other actions, to replace the Chief Executive Officer), https://www.prnewswire.com/news-releases/doma-perpetual-sends-letter-urging-board-of-directors-of-inmode-ltd-to-resume-share-repurchase-program-302451097.html SOURCE DOMA Perpetual

, /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares outstanding, representing approximately 6.38 million ordinary shares.

In 2025, the Company repurchased approximately $127.4 million of its outstanding ordinary shares through share repurchase programs. Despite a challenging macroeconomic environment, the Company continues to generate strong cash flow and believes that repurchasing shares at its current valuation represents an attractive use of capital.

While management remains focused on navigating the ongoing regional conflict and maintaining a disciplined approach to capital allocation, the Company will continue to evaluate additional share repurchase programs and other capital allocation opportunities going forward.

The Company expects to fund repurchases under the program with available cash. Repurchases may be made from time to time in the open market or through other permitted means, subject to market conditions and applicable legal requirements. The program may be modified, suspended, or discontinued at any time at the Company's discretion.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com/.

Forward-Looking Statements

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

Logo - https://mma.prnewswire.com/media/1064477/5862039/InMode_Logo.jpg

SOURCE InMode Ltd.

Shares of InMode Ltd. (NASDAQ: INMD - Get Free Report) have received an average rating of "Hold" from the nine ratings firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and one has assigned a buy recommendation to the

Posted by Defense World Staff on Apr 13th, 2026

Shares of InMode Ltd. (NASDAQ:INMD – Get Free Report) have been assigned an average recommendation of “Hold” from the nine research firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and one has issued a buy recommendation on the company. The average 12 month target price among brokers that have covered the stock in the last year is $16.80.

Several research firms have commented on INMD. Canaccord Genuity Group set a $15.00 price target on InMode and gave the company a “hold” rating in a report on Wednesday, December 17th. Weiss Ratings reissued a “sell (d+)” rating on shares of InMode in a report on Thursday, January 22nd. Robert W. Baird set a $17.00 price target on InMode in a research report on Wednesday, February 11th. Finally, BTIG Research restated a “neutral” rating on shares of InMode in a research report on Monday, January 26th.

View Our Latest Analysis on InMode

InMode Stock Performance NASDAQ INMD opened at $13.53 on Monday. InMode has a twelve month low of $12.72 and a twelve month high of $16.74. The stock has a market capitalization of $857.26 million, a PE ratio of 9.40 and a beta of 2.12. The stock has a 50-day simple moving average of $14.00 and a 200 day simple moving average of $14.45.

InMode (NASDAQ:INMD – Get Free Report) last posted its quarterly earnings data on Tuesday, February 10th. The healthcare company reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.04. InMode had a return on equity of 14.52% and a net margin of 25.33%.The business had revenue of $103.85 million during the quarter, compared to analysts’ expectations of $104.64 million. During the same quarter in the previous year, the firm earned $0.42 EPS. The firm’s revenue was up 6.1% compared to the same quarter last year. As a group, equities research analysts forecast that InMode will post 1.75 EPS for the current fiscal year.

Institutional Investors Weigh In On InMode A number of large investors have recently bought and sold shares of the business. Doma Perpetual Capital Management LLC grew its position in InMode by 26.8% during the 3rd quarter. Doma Perpetual Capital Management LLC now owns 2,838,431 shares of the healthcare company’s stock worth $42,293,000 after acquiring an additional 599,108 shares during the last quarter. Millennium Management LLC boosted its position in InMode by 111.4% in the 4th quarter. Millennium Management LLC now owns 1,778,681 shares of the healthcare company’s stock valued at $26,129,000 after buying an additional 937,376 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in InMode by 48.9% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,422,635 shares of the healthcare company’s stock valued at $20,899,000 after buying an additional 466,891 shares during the last quarter. Cooper Creek Partners Management LLC bought a new position in InMode in the 3rd quarter valued at $14,980,000. Finally, Ancient Art L.P. bought a new position in InMode in the 3rd quarter valued at $14,254,000. 68.04% of the stock is currently owned by institutional investors.

About InMode (Get Free Report)

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.

See Also Five stocks we like better than InMode

Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEApplied Industrial Technologies (NYSE:AIT) vs. GEA Group (OTCMKTS:GEAGF) Head-To-Head Analysis

NEXT HEADLINE »Lithium Americas Corp. (TSE:LAC) Given Average Recommendation of “Hold” by Analysts

, /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter of 2026.

First Quarter 2026 Highlights:

●  Quarterly GAAP revenues of $82.0 million, compared to $77.9 million in the first quarter of 2025.

●  Quarterly revenues from consumables and service of $21.4 million, an increase of 6% compared to the first quarter of 2025.

●  GAAP operating income of $10.1 million, *non-GAAP operating income of $14.0 million.

●  Total cash position of $537.2 million as of March 31, 2026, including cash and cash equivalents, marketable securities and short-term bank deposits.

●  As of March 31, 2026, we completed the repurchase of 2.55 million ordinary shares pursuant to our share repurchase program, returning $34.8 million of capital to shareholders ($3.6 million of which was paid during the second quarter of 2026).

●  Announced CFO transition; Yair Malca steps down and will support an orderly transition as a consultant.

●  Board transition: Dr. Michael Anghel resigns; Dr. Hadar Ron appointed Interim Chair of the Board.

U.S. GAAP Results

(U.S. dollars in thousands, except for per share data)

Q1 2026

Q1 2025

Revenues

$82,017

$77,874

Gross Margins

75 %

78 %

Operating Margins

12 %

20 %

Net Income

$11,562

$18,201

Earnings per Diluted Share

$0.18

$0.26

*Non-GAAP Results

(U.S. dollars in thousands, except for per share data)

Q1 2026

Q1 2025

Gross Margins

75 %

79 %

Operating Margins

17 %

23 %

Net Income

$15,872

$21,395

Earnings per Diluted Share

$0.25

$0.31

*Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A
reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements included in this release.
Non-GAAP results exclude share-based compensation, expenses related to independent transaction committee review (representing non-
recurring cost) and related income tax adjustments where applicable.

Management Comments

"While the macroeconomic environment remains challenging, our total revenue this quarter reached our expectations, however our profitability was lower than expected," said Moshe Mizrahy, Chief Executive Officer of InMode.  "We are continuing to re-shape our organization in North America and in Europe by enhancing our sales and management teams. While the demand in the aesthetics market may be deferred, it will not be diminished, and we believe we are well positioned for its return."

First Quarter 2026 Financial Results

Total GAAP revenues for the first quarter of 2026 were $82.0 million, an increase of 5% compared to $77.9 million in the first quarter of 2025. 

Yair Malca, Chief Financial Officer of InMode added, "We are encouraged to report that Q1 revenue increased 5% year over year, with the U.S. contributing meaningfully to this growth. These results reflect our ability to execute consistently, even in a softer market environment and expand outside of the U.S."

GAAP gross margin for the first quarter of 2026 was 75%, compared to 78% for the first quarter of 2025.

*Non-GAAP gross margin for the first quarter of 2026 was 75%, compared to 79% for the first quarter of 2025.

GAAP operating margin for the first quarter of 2026 was 12%, compared to 20% in the first quarter of 2025.
*Non-GAAP operating margin for the first quarter of 2026 was 17%, compared to 23% for the first quarter of 2025. These decreases were primarily attributable to the increase in cost of goods, the new structure of the North America sales team implemented towards end of 2025 and subsidiary establishments in the latter part of 2025.

InMode reported GAAP net income of $11.6 million, or $0.18 per diluted share, in the first quarter of 2026, compared to $18.2 million, or $0.26 per diluted share, in the first quarter of 2025. On a *non-GAAP basis, InMode reported net income of $15.9 million, or $0.25 per diluted share, in the first quarter of 2026, compared to $21.4 million, or $0.31 per diluted share, in the first quarter of 2025.

As of March 31, 2026, InMode had cash and cash equivalents, marketable securities and short-term bank deposits of $537.2 million.

"In a quarter marked by ongoing macroeconomic uncertainty, we remained focused on what we can control: driving profitability, generating cash, and operating the business as usual. We also returned meaningful capital to shareholders, repurchasing $127.4 million of shares during 2025 and $52.7 million year to date under our new 2026 repurchase program, representing 3.86 million shares. With our strong financial position and continued flexibility, we remain well positioned to pursue a full range of capital allocation opportunities," concluded Malca.

Departure of Chairman; Resignation of Chief Financial Officer

The Company announced today that Dr. Michael Anghel has resigned from the Company's Board of Directors, effective May 5, 2026. His decision was not related to any disagreements with the Company's management, Board, or operations. The Company thanks Dr. Anghel for his service and wishes him continued success.

Dr. Hadar Ron has been appointed Interim Chair of the Board, effective immediately.

Separately, Yair Malca has stepped down from his role as Chief Financial Officer, effective May 5, 2026. The Company appreciates his contributions and thanks him for his service.

To support a smooth transition, Mr. Malca will remain engaged with the Company in a consulting capacity for at least six months.

2026 Financial Outlook

Management provided an outlook for the full fiscal year ending December 31, 2026. Based on current estimates, management expects:

Revenues between $365 million and $375 million *Non-GAAP gross margin between 74% and 76% *Non-GAAP income from operations to be between $73 million and $78 million *Non-GAAP earnings per diluted share between $1.33 and $1.38 This outlook is not a guarantee of future performance, and stockholders should not rely on such forward-looking statements. See "Forward-Looking Statements" for additional information.

*Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation, expenses related to independent transaction committee review (representing non-recurring cost) and related income tax adjustments where applicable.

However, these estimates are based on management's current estimates, which may be updated. 

The Current Situation in Israel

Regarding the current situation in Israel, on October 9, 2025, a new cease-fire agreement between Hamas and Israel began, and the hostilities have formally paused after two years of conflicts.

Moreover, On February 28, 2026, the United States and Israel launched coordinated joint military strikes against Iran, targeting military, governmental, and nuclear-related sites. Iran subsequently responded with missile and drone attacks against targets in the region and sought to restrict commercial shipping traffic through the Strait of Hormuz. On April 7, 2026, a two-week ceasefire established and was extended on April 21, 2026, by the U.S government, amid ongoing negotiations, while a U.S. naval blockade of Iran continued.

The scope and severity of ongoing conflicts in Gaza, Northern Israel, Lebanon, Iran, and the broader region are unpredictable and could escalate any time. To date, our operations have not been materially affected. We continue to monitor political and military developments closely and examine the consequences for our operations and assets. 

Use of Non-GAAP Financial Measures

In addition to InMode's operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, non-GAAP operating margin, non-GAAP gross margin and non-GAAP income from operations. Because these measures are used in InMode's internal analysis of financial and operating performance, management believes they provide investors with greater transparency of its view of InMode's economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode's GAAP operating results, allows investors to more effectively evaluate and compare InMode's performance to that of its peers, although InMode's presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release. Reconciliations of non-GAAP gross margin, non-GAAP income, and non-GAAP earnings for management's projections of such non-GAAP financials for the 2026 fiscal year are not available without unreasonable effort due to the variability, complexity and limited visibility of certain reconciling items. These reconciling items could have a significant and unpredictable impact on our future GAAP results.

Conference Call Information

Mr. Moshe Mizrahy, Chief Executive Officer, Dr. Michael Kreindel, Co-Founder and Chief Technology Officer and Mr. Yair Malca, Chief Financial Officer, will host a conference call today, May 6, 2026, at 8:30 a.m. Eastern Time to discuss the first quarter 2026 financial results.

The Company encourages participants to pre-register for the conference call using the following link: 

https://dpregister.com/sreg/10207930/103b6ad5664.

Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.

U.S./Canada Toll-Free Dial-in Number: 1-833-316-0562
Israel Toll-Free Dial-in Number: 1-80-921-2373
International Dial-in Number: 1-412-317-5736
Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=7s0HUsXw

At:
8:30 a.m. Eastern Time
5:30 a.m. Pacific Time

The conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/events-presentations/. A replay of the conference call will be available from May 6, 2026, at 12 p.m. Eastern Time to May 20, 2026, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers: 

Replay Dial-in U.S. /Canada TOLL-FREE: 1-855-669-9658
Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088
Replay Pin Number: 8622780

To access the replay using an international dial-in number, please select the link below:

https://services.choruscall.com/ccforms/replay.html

A replay of the conference call will also be available for 90 days on InMode's website at https://inmodemd.com/investors/.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Forward-Looking Statements 

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

INMODE LTD.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(U.S. dollars in thousands, except for per share data)

(Unaudited)

Three months ended

March 31,

2026

2025

REVENUES

82,017

77,874

COST OF REVENUES

20,465

16,963

GROSS PROFIT

61,552

60,911

OPERATING EXPENSES:

Research and development

3,542

2,895

Sales and marketing

42,932

39,727

General and administrative

5,022

2,671

TOTAL OPERATING EXPENSES

51,496

45,293

OPERATING INCOME

10,056

15,618

Finance income, net

4,296

6,859

INCOME BEFORE INCOME TAXES

14,352

22,477

INCOME TAXES

2,790

4,276

NET INCOME

11,562

18,201

EARNINGS PER SHARE:

Basic

0.18

0.26

Diluted

0.18

0.26

WEIGHTED AVERAGE NUMBER OF SHARES
OUTSTANDING USED IN COMPUTATION OF EARNINGS PER
SHARE (in thousands)

Basic

63,401

68,760

Diluted

63,942

69,435

INMODE LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands, except for per share data)

(Unaudited)

March 31,

2026

December 31,

2025

Assets

CURRENT ASSETS:

Cash and cash equivalents

394,295

302,543

Marketable securities

57,032

83,632

Short-term bank deposits

85,832

169,159

Accounts receivable, net of allowance for credit losses

40,703

43,504

Prepaid expenses and other receivables

31,509

25,733

Inventories

71,408

74,050

         TOTAL CURRENT ASSETS

680,779

698,621

    NON-CURRENT ASSETS:

Accounts receivable, net of allowance for credit losses

5,210

3,005

Deferred income tax assets

52,922

53,230

Operating lease right-of-use assets

8,631

8,274

Property and equipment, net

2,595

2,599

Other investments

700

700

TOTAL NON-CURRENT ASSETS

70,058

67,808

TOTAL ASSETS

750,837

766,429

Liabilities and shareholders' equity

CURRENT LIABILITIES:

Accounts payables

16,853

17,912

Contract liabilities

16,369

12,093

Other liabilities

44,131

40,739

TOTAL CURRENT LIABILITIES

77,353

70,744

    NON-CURRENT LIABILITIES:

Contract liabilities

2,745

3,043

Other liabilities

4,657

4,436

Operating lease liabilities

4,829

5,008

TOTAL NON-CURRENT LIABILITIES

12,231

12,487

TOTAL LIABILITIES

89,584

83,231

TOTAL SHAREHOLDERS' EQUITY

661,253

683,198

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

750,837

766,429

INMODE LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. dollars in thousands, except for per share data)

(Unaudited)

Three months ended

March 31,

2026

2025

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income

11,562

18,201

Adjustments required to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

175

174

Share-based compensation expenses

2,699

2,518

Change in allowance for credit losses of trade receivable

525

(94)

Gains on marketable securities, net

–

(2)

Finance expenses (income), net

719

(1,574)

Deferred income taxes, net

327

896

Changes in operating assets and liabilities:

Decrease in accounts receivable (current and non-current)

72

4,544

Increase in other receivables

(5,866)

(3,532)

Decrease (increase) in inventories

2,642

(4,233)

Increase (decrease) in accounts payable

(1,059)

1,270

Decrease in other liabilities (current and non-current)

(388)

(3,287)

Increase (decrease) in contract liabilities (current and non-current)

3,978

(837)

Net cash provided by operating activities

15,386

14,044

CASH FLOWS FROM INVESTING ACTIVITIES:

Investment in short-term deposits

(84,912)

–

Proceeds from short-term deposits

167,658

31,297

Purchase of fixed assets

(172)

(85)

Purchase of marketable securities

(9,727)

(20,877)

Proceeds from sale of marketable securities

–

3,003

Proceeds from maturity of marketable securities

36,256

62,147

Net cash provided by investing activities

109,103

75,485

CASH FLOWS FROM FINANCING ACTIVITIES:

Tax withholding related to vesting of restricted share units

(1,802)

-

Repurchase of ordinary shares

(31,241)

(99,960)

Exercise of options

617

494

Net cash used in financing activities

(32,426)

(99,466)

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH
    EQUIVALENTS

(311)

556

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

91,752

(9,381)

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

302,543

155,329

CASH AND CASH EQUIVALENTS AT END OF PERIOD

394,295

145,948

INMODE LTD.

CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS

(U.S. dollars in thousands, except for per share data)

(Unaudited)

Three months ended March 31,

2026

2025

Revenues by Category:

Capital Equipment revenues - United States

33,669

41 %

29,542

38 %

Capital Equipment revenues - International

26,985

33 %

28,133

36 %

Total Capital Equipment revenues

60,654

74 %

57,675

74 %

Consumables and service revenues

21,363

26 %

20,199

26 %

Total Revenue

82,017

100 %

77,874

100 %

Three months ended March 31,

2026

2025

%

%

United
States

International

Total

United
States

International

Total

Revenues by Technology:

Minimal-Invasive

75

80

77

93

79

87

Hands-Free

1

1

1

3

2

3

Non-Invasive

24

19

22

4

19

10

100

100

100

100

100

100

INMODE LTD.

RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF

 INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME 

(U.S. dollars in thousands, except for per share data)

(Unaudited)

Three months ended March 31, 2026

Three months ended March 31, 2025

GAAP

Stock Based
Compensation

Expenses
Related to
Independent
Transaction
Committee Review

Non-GAAP

GAAP

Stock Based
Compensation

Non-GAAP

REVENUES

82,017

–

–

82,017

77,874

–

77,874

COST OF REVENUES

20,465

(314)

–

20,151

16,963

(310)

16,653

GROSS PROFIT

61,552

314

–

61,866

60,911

310

61,221

OPERATING EXPENSES:

Research and development

3,542

(268)

–

3,274

2,895

(222)

2,673

Sales and marketing

42,932

(1,861)

–

41,071

39,727

(1,763)

37,964

General and administrative

5,022

(256)

(1,262)

3,504

2,671

(223)

2,448

TOTAL OPERATING EXPENSES

51,496

(2,385)

(1,262)

47,849

45,293

(2,208)

43,085

OPERATING INCOME

10,056

2,699

1,262

14,017

15,618

2,518

18,136

Finance income, net

4,296

–

–

4,296

6,859

–

6,859

INCOME BEFORE INCOME TAXES

14,352

2,699

1,262

18,313

22,477

2,518

24,995

INCOME TAXES

2,790

(349)

–

2,441

4,276

(676)

3,600

NET INCOME

11,562

3,048

1,262

15,872

18,201

3,194

21,395

EARNINGS PER SHARE

Basic

0.18

0.25

0.26

0.31

Diluted

0.18

0.25

0.26

0.31

WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING USED IN
COMPUTATION OF NET INCOME PER
SHARE (in Thousands)

Basic

63,401

63,401

68,760

68,760

Diluted

63,942

64,494

69,435

69,611

Logo - https://mma.prnewswire.com/media/1064477/5954733/InMode_Logo.jpg

SOURCE InMode LTD.

, /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events:

Barclays Virtual West Coast Bus Trip

Presenters: Yair Malca, Outgoing Chief Financial Officer and Moshik Itzkovich, Senior VP of Finance

Format: Virtual investor bus tour

When: Wednesday, May 20

Jefferies Global Healthcare Conference

Presenters: Yair Malca, Outgoing Chief Financial Officer and Moshik Itzkovich, Senior VP of Finance

Format: In-person fireside chat moderated by Matt Taylor, Senior Equity Analyst and one-on-one meetings

When: Wednesday, June 3, fireside chat at 12:45 pm ET

Location: New York, NY

A live webcast of the presentation can be accessed here.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Forward-Looking Statements

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

Investor Relations Contact:

Miri Segal-Scharia

MS-IR LLC

[email protected]

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

SOURCE InMode Ltd.

InMode Ltd. remains a global leader in minimally-invasive aesthetics, with proprietary RF and laser technologies and a strong international growth trajectory. I maintain a Strong Buy rating for INMD, citing undervaluation, robust free cash flow, a fortress balance sheet, and aggressive share repurchases. U.S. market saturation and sales execution remain challenges, but leadership changes and new product launches are driving positive cultural and operational shifts.